Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001309884 | SCV001499398 | uncertain significance | Inflammatory bowel disease | 2021-02-26 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs746523858, ExAC 0.001%). This sequence change replaces arginine with tryptophan at codon 124 of the IL10 protein (p.Arg124Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant has not been reported in the literature in individuals with IL10-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). |
Ambry Genetics | RCV004034218 | SCV003594328 | uncertain significance | not specified | 2021-12-06 | criteria provided, single submitter | clinical testing | The c.370C>T (p.R124W) alteration is located in exon 3 (coding exon 3) of the IL10 gene. This alteration results from a C to T substitution at nucleotide position 370, causing the arginine (R) at amino acid position 124 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |